• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Joshua Benner Discusses the Importance of PQA's New Opioid Measures


The new opioid quality measures by the Pharmacy Quality Alliance are a first step forward for improving use of prescription opioids.

At its 10th Annual Meeting in Arlington, Virginia, the Pharmacy Quality Alliance announced its new opioid quality measures, and RxAnte helped in the development and testing of these measures, explained Joshua Benner, PharmD, ScD, executive vice president of strategy and corporate development at Millennium Health and former president and chief executive officer of RxAnte.

The measures are just a first step, but what is important is that they develop a common definition of what appropriate use of prescription opioids actually is, Dr Benner said.

"As we develop experience using those measures in practice, we'll learn more about how they should be refined over time," he said.

Related Videos
Dr Mrinal Gounder
Mikkael Sekeres, MD
Jennifer Brown, MD, PhD
Ted Okon, MBA, of Community Oncology Alliance, during a Zoom video interview
Virginia Kaklamani, MD | image credit: uthscsa.edu
Ruben A. Mesa, MD, president and executive director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Related Content
© 2023 MJH Life Sciences
All rights reserved.